Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan
· Delayed Price · Currency is TWD 77.30
+6.10 (8.57%)
Apr 28, 2026, 1:30 PM CST
Gongwin Biopharm Holdings Market Cap
Gongwin Biopharm Holdings has a market cap or net worth of 9.48 billion as of April 28, 2026. Its market cap has decreased by -27.70% in one year.
Market Cap
9.48B
Enterprise Value
7.93B
Revenue
36.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
77.30
Market Cap Chart
Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 9.48B, an increase of 6.90%. That is a compound annual growth rate of 0.73%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEngine | 7.82B |
| Adimmune | 7.54B |
| Acepodia | 7.25B |
| TaiGen Biopharmaceuticals Holdings | 7.19B |
| CHO Pharma | 9.48B |
| Mycenax Biotech | 6.08B |
| Sinphar Pharmaceutical | 6.02B |
| Savior Lifetec | 6.01B |